Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

Bibliographic Details
Main Author:	Soleymani Majd, H
Other Authors:	COVID Surg Collaborative
Format:	Journal article
Language:	English
Published:	Oxford University Press 2022

Similar Items

Bacillus Calmette-Guerin (BCG): the adroit vaccine
by: Oluwafolajimi A. Adesanya, et al.
Published: (2021-02-01)

Bacillus Calmette-Guérin (BCG)-Vaccine Is it giving a protection against SARS-CoV-2?
by: Mehnaz Tanveer, et al.
Published: (2022-06-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
by: Fernando Korkes, et al.
Published: (2021-02-01)

Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations
by: Ekaterini Goudouris, et al.
Published: (2023-03-01)

A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination
by: Mihoko Furuichi, et al.
Published: (2020-11-01)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
by: Centola Michael, et al.
Published: (2007-05-01)

The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
by: Konstantin Föhse, et al.
Published: (2023-02-01)

Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics
by: Oluwafolajimi A. Adesanya, et al.
Published: (2020-12-01)

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
by: Konstantin Föhse, et al.
Published: (2023-05-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
by: Jinmiao Lu, et al.
Published: (2022-11-01)

Effectiveness Of Bacillus Calmette Guerin (BCG) Vaccination In The Prevention Of Tuberculosis Of Skin : A Case Control Study.
by: Zodpey S.P, et al.
Published: (1998-01-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
by: Paola Villanueva, et al.
Published: (2022-01-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
by: Paola Villanueva, et al.
Published: (2022-01-01)

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
by: Akihito Kawai, et al.
Published: (2022-11-01)

Repurposing of bacillus Calmette-Guerin (BCG): Prevention, remission or cure in Type 1 diabetes?
by: Om Prakash Gupta
Published: (2015-01-01)

The Effectiveness of BCG (Bacillus-Calmette Guerin) Immunization to the Tuberculosis Incidence on Children at Banyuasin Regency
by: Wulanda Ayu Febri, et al.
Published: (2018-01-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
by: Rolandas Selvestravičius, et al.
Published: (2016-09-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
by: Sung-Hsi Wei, et al.
Published: (2018-04-01)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
by: Paola Villanueva, et al.
Published: (2023-04-01)

Systemic bacillus Calmette-Guérin (BCG) infection and accompanying warm autoimmune haemolytic anaemia following intravesical BCG immunotherapy
by: Alper Tuna Güven, et al.
Published: (2023-08-01)

Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
by: Ofer N Gofrit, et al.
Published: (2019-01-01)

Bacillus of Calmette and Guérin (BCG) and the risk of leprosy in Ciudad del Este, Paraguay, 2016–2017
by: Nancy Carolina Cuevas, et al.
Published: (2021-09-01)

Observational study to estimate the changes in the effectiveness of bacillus Calmette–Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
by: Punam Mangtani, et al.
Published: (2017-07-01)

Bacillus Calmette–Guérin Immunotherapy for Cancer
by: Fabíola Cardillo, et al.
Published: (2021-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.
by: Michael Favorov, et al.
Published: (2012-01-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
by: Sarah Hamdy Soliman, et al.
Published: (2023-01-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
by: Renata Monteiro-Maia, et al.
Published: (2014-09-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
by: Maria Carolina Sisco, et al.
Published: (2020-05-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
by: Yanin Chavarri-Guerra, et al.
Published: (2019-12-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
by: Patricia Méndez-Samperio
Published: (2019-06-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
by: Badria Al Waili, et al.
Published: (2021-02-01)

Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)

INFLUENCE OF BCG (BACILLUS CALMETTE-GUÉRIN) ON THE MATURATION OF HUMAN DENDRITIC CELL (DCS) DIFFERENTIATED FROM MONOCYTES
by: TS Lima, et al.
Published: (2023-10-01)

Immunogenicity of Bacillus Calmette-Guérin in pigs: potential as a translational model of non-specific effects of BCG
by: Kristoffer Jarlov Jensen, et al.
Published: (2023-07-01)

Growth inhibition of HeLa cell by internalization of <it>Mycobacterium bovis </it>Bacillus Calmette-Guérin (BCG) Tokyo
by: Asahina Izumi, et al.
Published: (2009-12-01)

Bovis Bacillus Calmette–Guerin (BCG) infection induces exosomal miRNA release by human macrophages
by: Shamila D. Alipoor, et al.
Published: (2017-05-01)